Navigation Links
5th International Scientific Symposium on Tourette Syndrome to Focus on Latest Research and Treatment
Date:5/28/2009

Rare Opportunity to Benefit from Most Current Findings

BAYSIDE, N.Y., May 28 /PRNewswire-USNewswire/ -- Once every five years the most prestigious and internationally renowned scientists and medical experts on Tourette Syndrome (TS) -- the complex neurological disorder that causes involuntary movements and sounds -- convene to disseminate and share the latest advances and findings about this baffling condition.

As part of its basic mission to identify current research and treatment advances and to facilitate meaningful networking among basic and clinical scientists, the national Tourette Syndrome Association (TSA) is sponsoring the 5th International Scientific Symposium on Tourette Syndrome from June 12-14 at the Downtown Marriott in New York City.

Since the last such Symposium in 2004, numerous advances have been made in both understanding the biological underpinnings as well as the application of new and refined approaches to clinical care. Also, due to the highly complex scientific and treatment issues relevant to TS, the meeting program has been developed specifically to provide information that will be of interest to both basic and clinical researchers as well as allied medical practitioners. Specifically, the Symposium planning committee has chosen a series of program topics designed to set the agenda for future TS research initiatives and also with a view toward improving clinical care.

Among the critical issues to be discussed at this meeting will be the emerging and experimental procedure deep brain stimulation (DBS), the development of animal models and advances in cognitive behavioral therapy for reducing tic symptoms.

The Symposium co-chairs are Peter J. Hollenbeck, Ph.D., Purdue University; Jonathan Mink, M.D., Ph.D., University of Rochester Medical Center and John T. Walkup, Johns Hopkins School of Medicine. The Steering Committee which developed the program schedule is chaired by Kevin Black, M.D., Washington University School of Medicine.

The Symposium faculty will present on genetics, neuroimaging, neuropathology, clinical trials (medication and behavioral), epidemiology, neurophysiology, neuro-immunology and descriptive/diagnostic clinical science. Invited speakers are highly renowned experts from the Centers for Disease Control and Prevention, Harvard University, University College London, Yale University School of Medicine, UCLA, as well as physicians from Israel, Sweden and the Netherlands. Anticipated attendance at the Symposium will exceed 200 national and international registrants.

The TSA Early Career Research Award will be presented to the TSA grant recipient Nicole Calakos, M.D., Ph.D for her work on synaptic and circuit level insights for TS and OCD using mouse models. In addition, the TSA Lifetime Achievement Award will be presented to Joseph Jankovic, M.D., in recognition of his many decades of outstanding contributions to TS research, professional education and clinical care for all people touched by TS.

"The perception of Tourette Syndrome has gone from being a curiosity and considered a very rare disorder to one that is increasingly recognized as being an important neurobehavioral condition," said Dr. Walkup, Johns Hopkins School of Medicine, and the Chair of TSA's national Medical Advisory Board. "Scientific and medical researchers are devoting more and more effort to understanding this unique disorder which has both neurological and psychiatric aspects," he added.

Marked by involuntary movements and vocalizations called tics, Tourette Syndrome is an inherited neurological condition frequently misunderstood and misdiagnosed, affecting more than 200,000 Americans. Founded in 1972, the national Tourette Syndrome Association celebrates 37 years of service to the TS community as the only national, voluntary health organization for people with TS. For more information visit http://tsa-usa.org.

    Contact: Tracy Colletti-Flynn
    718-224-2999


'/>"/>
SOURCE Tourette Syndrome Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 30, 2016 , ... Mercy College is expanding ... The following programs will be expanding due to high demand: Master of Business Administration ... will begin this summer. , School of Business Graduate Program Chair Dr. ...
(Date:4/29/2016)... ... April 29, 2016 , ... Shamangelic Healing, Sedona Arizona's ... brand Alpha BRAIN and New Mood Daily-Stress Formula for brain optimization and wellness ... to the store is just one more way Shamangelic Healing supports people’s quest ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. ... of best seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics related to Death ... podcasted thereafter . Dr. Bernie Siegel, author of a plethora of essential ...
(Date:4/29/2016)... ... April 29, 2016 , ... A new study ... severe congenital diaphragmatic hernia have better survival rates if surgery is performed early. ... condition where the diaphragm fails to form completely, letting abdominal organs into the ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... patented products, announces the Gyrociser, an exercise invention which aids in proper muscle ... says Scott Cooper, CEO and Creative Director of World Patent Marketing. "Globalization has ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery systems, ... PIONEERS 2016 conference, presented by Joseph Gunnar & ... New York . Nadav Kidron , CEO ... Presentation Details:   PIONEERS 2016, ...
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
(Date:4/27/2016)... PARIS , April 27, 2016 ... Year-Over-Year Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) ... today announced its sales for the first quarter ended ... business and the execution of its commercial strategy. ...
Breaking Medicine Technology: